mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2020). On theSindex it has a DataRank of 0. It has been cited 460 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI152183
National Institutes of Health
Grant: U01AI154659
National Institutes of Health
Grant: R01HG010863
National Institutes of Health
Grant: P50GM115305
National Institutes of Health
Grant: R21AI139021
National Institutes of Health
Grant: 5R21AI139021-02
Single Cell definition of pathogenic T cells in Drug-induced Stevens-Johnson-Syndrome/Toxic epidermal necrolysis
National Institutes of Health
Grant: 1R01AI152183-01
Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)
National Institutes of Health
Grant: 1R01HG010863-01
Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors
National Institutes of Health
Grant: 5U01AI154659-04
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
National Institutes of Health
Grant: 5P50GM115305-05
Improving Prediction of Drug Action
Fields of Study
Keywords
Sustainable Development Goals